Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05626946
Other study ID # 2022PI165
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date May 2023
Est. completion date June 2023

Study information

Verified date November 2022
Source Central Hospital, Nancy, France
Contact Victoire BOURDAIRE, PH
Email V.BOURDAIRE@chru-nancy.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The rate of emergency room visits is high at the extremes of age, with patients aged 75 or over accounting for 12% of emergency room visits, and the time they spend there is significantly longer than that of younger patients. Nursing Home residents represent 14% of these emergency room visits and only 5% of them on average are not hospitalised and return to their original Nursing Home. A retrospective study of patients aged 75 and over referred to the emergency department of the Nancy Hospital by the Nursing Homes over a six-month period showed that nearly 30% of patients aged 75 and over referred by their Nursing Home were rehospitalized during the period studied, 1/3 for the same reason and 2/3 for other reasons. The intervention of an Advanced Practice Nurse (IPA) attached to geriatric practice, among other things, as an interface between Nursing Home and the hospital therefore seems to have its place in improving the care pathway for the elderly. The assessment by an Advanced geriatric Practice Nurse of residents of Nursing Home aged 75 and over in Grand Nancy area one week after a visit to the emergency room significantly reduces the number of new visits to the emergency room by these residents over a follow-up period of seven months, compared with residents of Nursing homes aged 75 and over (outside Grand Nancy area) who do not benefit from an assessment by an Advanced Practice Nurse.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 400
Est. completion date June 2023
Est. primary completion date June 2023
Accepts healthy volunteers No
Gender All
Age group 75 Years and older
Eligibility Inclusion Criteria: - Person who has received full information on the organization of the research and has not objected to the use of this data - Elderly men and women 75 years of age and older at the time of the emergency room visit - Having for main residence one of the nursing homes - Administratively present in the emergency department Exclusion Criteria: - People under 75 years of age - Residing at home or in a senior residence - Referred by an inpatient department (rehabilitation department)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Observation
Observation

Locations

Country Name City State
France CHRU de Nancy Vandoeuvre les Nancy

Sponsors (3)

Lead Sponsor Collaborator
Central Hospital, Nancy, France Mahmut GUNDESLI MD, Manon DUPRE, internship

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary RATE OF REHOSPITALISATION OVER THE ENTIRE FOLLOW-UP PERIOD IN THE 2 GROUPS OF PATIENTS WITH AND WITHOUT ADVANCED PRACTICE NURSE INTERVENTION through study completion, an average of 7 months
Secondary PROPORTION OF AVOIDABLE VISITS FOR A REASON SIMILAR TO THE REASON FOR INITIAL HOSPITALISATION through study completion, an average of 7 months
Secondary PROPORTION OF PATIENTS DIRECTLY ADMITTED TO THE NANCY HOSPITAL GERIATRIC UNIT through study completion, an average of 7 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01273610 - Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer Phase 2